InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Puissance Capital Management LP. Director active across 1 company, notably Bellerophon Therapeutics, Inc.. Aggregated, 1 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €106k. Activity tracked since 13 October 2023. The latest transaction was filed on 13 October 2023 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration